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INTRODUCTION
Drug use in developing countries is often characterized by excessive and inappropriate prescribing'. This exposes patients to the risk of ineffective treatment and adverse side-effects, and contributes to unnecessarily high costs.
A number of research reports and review articles have demonstrated the importance of studying prescribing behaviour24.
China launched economic reforms in the late 1970s with the aim of transforming its planned economy into a so-called 'socialist market economy'. These reforms Correspondence to: Dr Sheng-Ian Tang, The Institute of Development Studies, University of Sussex, Brighton BN 1 9RE, UK have included the decentralization of public finance, increased autonomy for stated-owned enterprises and institutions, and liberalization of prices. These changes have affected the health sector and, in consequence, drug use.
Government health budgets have grown less quickly than total health expenditure, and health facilities have become increasingly dependent on user charge^^,^. The sale of drugs is an important source of income for health providers. One survey in rural China found that drug fees accounted for 72%-83% of the average charge per outpatient visit'. The National Health Services Survey (NHSS) showed that township health centres earned 69% of their income from drug sales in 1986 and 77% in 19928.
Many doctors and health workers at village, township, and county levels have not received the same level of formal medical training as have their counterparts in western countries. Yet they can supply all drugs except narcotics and major tranquillizers. Little is known about their prescribing practices. This paper presents findings on drug use at health facilities in three poor rural counties in China, discusses the factors that affect drug use in these facilities, and concludes with a discussion of the implications of these findings for policy.
METHODOLOGY

Selection of study health facilities
Drug use was studied as part of a larger study of the financing of health services in three poor rural counties: Donglan (Guangxi province), Shibing (Guizhou province) and Xunyi (Shaanxi province). All three county general hospitals and six township health centres (two from each county) were included in the sample. The township health centres were chosen from the townships that represent different levels of economic development6. The village health stations were not included, since they did not keep records of prescriptions.
Data collection
For each month in 1993, 100 outpatient records were randomly sampled in each county hospital and 50 in each health centre. The total number of prescriptions analysed was 7182, since all but 10 outpatient visits to the county hospitals and nine to the township health centres resulted in prescriptions. Gilson and her associates reported a similar low proportion of outpatient visits without prescriptions in Tanzania2. The methodology used in extracting information from the prescriptions was similar to the one recommended by the WHO'. Prescriptions of Chinese herbs were not included in the study because of difficulties in assessment.
A number of health service managers were interviewed and focus group discussions were held with health workers and peasants in the study counties. In addition, regular health facility accounting reports were collected. The data were collected by researchers from Shanghai Medical University and three local medical colleges with the assistance of local health workers. 
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RESULTS
This section presents the results of the prescription survey. It compares the average number of drug items per prescription, the proportion of prescriptions with antibiotics, the proportion of prescriptions with an injection, and average cost per prescription between the health facilities studied and with similar indicators from other countries. These comparisons provide a rough measure of the appropriateness of prescribing behaviour. It also discusses the influence on prescribing behaviour of the system of government health finance; regulation, training and monitoring; and users' attitudes and ability to pay. Average number of drug items per prescription average number of drugs per prescription was particu- Table 1 shows the average number of drugs per larly high in Xunyi's township health centres, where prescription in the county hospitals and township health 43% of the prescriptions contained more than four centres. Doctors prescribed fewer drugs per prescription drugs. in the former than in the latter. The average prescription in all the study health facilities, except Xunyi's township health centres, was between two and three. These prescriptions were relatively large compared to those in many other developing countries ( Figure 1 ). The
Proportion of prescriptions with antibiotics
Between one third and one half of the prescriptions issued by most of the facilities and over half those issued (Table 2) . A substantial number of prescriptions included two or more antibiotics. The proportion of prescriptions issued by the health facilities studied which included antibiotics was relatively high compared with many other developing countries (see Figure 2 ).
Proportion of prescriptions with injections
Between a sixth and a quarter of prescriptions included an injection (Table 3) . These results lie in the uppermiddle range in comparison with studies of other selected developing countries ( Figure 3) . A considerable number of Xunyi's outpatient prescriptions also included an intravenous drip. Table 4 presents the average cost of prescriptions in the study health facilities. The lowest average cost of prescriptions (2.8 yuan) was found in the township health centres in Shibing, while the county hospital in Xunyi had the highest average cost (9.7 yuan). The average costs were higher in the county hospitals than in the township health centres. This probably reflected the different case mix at the county hospitals and the fact that a significant proportion of patients at these facilities were insured6. In order to assess the financial burden placed on the rural population by drug fees, the average per capita daily income was calculated, based on data for 1992 provided by county statistical bureaux. The average cost per prescription in township health centres was equal to 5.6,2.2 and 6.2 times the averageper capita daily income in Donglan, Shibing and Xunyi, respectively. The average cost of prescriptions in the county hospitals was even higher. These costs were higher than those reported for Indonesia during the early 1980s where the average cost of a health centre visit was equivalent to 1 day's income per capital0.
Average cost of prescriptions
Factors influencing drug use Government health care finance. The government's health care finance system strongly influences drug use. Health facilities depend on revenue from user charges, including drug sales. Almost every health facility in China has a pharmacy that sells Western drugs and/or manufactured Chinese drugs as well a Chinese herbs.
They charge a mark-up of 15% on Western products and 20% on Chinese products.
Salaries are fixed by central government. However, health workers are paid bonuses by their employers. The more revenue a health facility generates, the larger the bonuses it can pay. This provides an incentive for individual health workers to prescribe more items, particularly expensive products.
Regulation, training and monitoring. Prior to the economic reforms, the rural health services operated a de facto essential drugs policy. Figure 4 shows the structure of the system of drugs supply prior to the reforms. Almost all drugs were manufactured by the State Pharmaceutical Company and distributed through a chain of monopoly suppliers. The local drug companies tended to provide only a small number of basic drugs to the low level facilities. The transition from a centrally-planned to a marketoriented economy has been accompanied by a shift to a largely unregulated market for drugs. Drug manufacturers and suppliers now supply products to anyone who has the ability to pay for them. Indeed, drug companies are expected to maximize revenue and/or profits, a motivation which was confirmed in interviews with the directors of drug companies. They are under pressure to generate maximum turnover. Drug producers and drug companies employ a variety of strategies to increase sales". Some of them supply directly to the pharmaceutical departments of health facilities. Many offer commissions to those in charge of drug purchasing, and some offer bonuses to doctors who use new and expensive drugs.
Health facilities in the study counties still procure mainly (but not exclusively) from the county drug company, but this can no longer be guaranteed. These companies obtain drugs from more sources than previously. Since health facilities (including village health stations) can procure drugs from a variety of sources, it is not possible to prevent them from obtaining and selling any drug they wish.
The majority of health workers in health centres in poor townships have not graduated from medical college or university'*. There are, none the less, almost no limitations to the drugs they can prescribe and sell. This also applies to the village doctors, who are parttime farmers and health workers. Many people purchase drugs without seeing a health worker at all (between 44.5% in Donglan and 82.5% in Shibing). The most common sources of supply are health facilities, pharmacies, and the offices of private doctors (Table  5 ). In some areas, even veterinarians sell drugs for human use, according to the director of the Penan County Health Bureau. This demonstrates the almost complete lack of regulation of drug sales.
County health bureaux d o not monitor the performance of health workers, including their use of drugs, unless a medical accident occurs. Otherwise, the quality of medical care is monitored through the inclusion in the routine reports submitted by hospitals and health centres of indicators of service quality. One reason for the lack of effective regulation is that many county health bureaux d o not employ staff capable of monitoring the technical aspects of services. More significantly, neither the county health bureaux nor the county hospitals have any incentive to monitor the quality of services, since the government does not allocate funds for this purpose.
Users' attitudes and behaviour. G u o '~ has studied the influence of social factors on prescribing behaviour in the study counties through interviews and focus group discussions. He found that many peasants prefer doctors who prescribe several drugs. They also commonly believe that imported drugs are better than locally produced ones, injections are better than tablets, and expensive drugs are better than cheap ones.
User preferences appear to influence prescribing behaviour in rural China, as they d o in the USAI4. Many drugs are widely advertised through television, newspapers and magazines. These advertisements, which do not mention potential side-effects, have had a powerful effect. Guo13 reports that 9% of patients requested a specific drug when consulting a health worker.
Poor households find drugs very expensive. Interviews with health workers and focus group discussions revealed that poor peasants are often reluctant to seek treatment, even if they fall ill. Some health workers in the study counties reported that patients bring small amounts of money (1 or 2 yuan) and ask doctors to prescribe drugs which will cost less than that amount.
DISCUSSION
Impact of drug use on quality and cost of services
The present study found evidence of high levels of drug use, in comparison with a number of other developing countries. Almost every consultation with a health worker resulted in a prescription that included, on average, more than two drugs. A substantial proportion of prescriptions included antibiotics, and many were for an injectable item. These are crude indicators of the quality of prescribing behaviour, but they provide a general impression that more drugs are consumed than necessary. This has implications for the efficacy and potential risk of treatment, and for its cost. The quality of basic health services in many low-income countries is seriously compromised by drug shortages15. However, a study of Nepal reported by Chalkerf6 found that a better supply of essential drugs does not necessarily improve the quality of care. This appears to be the case in the study counties, where health facilities do not have drug shortages, but where drugs are not always appropriately used.
The high rate of antibiotic use is a matter for concern. Excessive use of antibiotics can lead to serious side effects and to the development of drug resistant bacterial7. There have been some studies of the problems with antibiotic use in China. Wang found that 13% of 2638 patients using antibiotics had harmful reactionsL8. Wu reported a study of 1039 deaf children in Beijing, whose deafness was due in 60% of the cases to the side-effects of antibiotic use, especially streptomycin", Another sign of inappropriate drug use is the report by Jiang of drug dependence among the elderly").
Health facilities in the study counties have increased their drug spending considerably since the early 1980s 7 dfUg producer Their use of these drugs is virtually unsupervised. The income of health workers is directly related to the volume of drugs they sell. One option for decreasing the pressure to increase sales would be to cut the link between the remuneration of health personnel and drug sales6. Such a policy would have to be accompanied by the development of alternative financing mechanisms for health facilities. Some of the more affluent villages, for example, pay their village doctors a salary and the profits from drug sales are paid directly into the village welfare fund. Many areas, however, may not be able to maintain adequate levels of funding for health facilities without the revenue from drug sales. Another option would be to limit the right to prescribe and sell certain products to those with defined levels of training. All health workers would be permitted to sell unregulated drugs freely at a price that includes a profit margin. Other drugs would only be prescribed and sold by licensed personnel. One strategy for limiting the incentive to prescribe costly products would be to set a fixed dispensing fee per prescription of regulated products.
A background paper reported in WDR93, Investing in Health, ranked China fairly low in terms of annual drug expenditure per capita. None the less, many people feel that drugs are too expensive in China. The cost of outpatient visits has become a barrier to care for the p~o r~,~. There are reports of poor patients who cannot afford a full course of prescribed drugs. This is not surprising since an outpatient visit costs almost as much as the average incomeper capita per week. This underlines the need to include measures to improve drug use in a programme of reforms aimed at providing the population with access to effective care at a reasonable cost. 
